In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study

por Lago, Igor Matos, Novaes, Gustavo Caires, Badran, André Vannucchi, Pavão, Rafael Brolio, Barbosa, Ricardo, de Figueiredo, Geraldo Luiz, Lima, Moysés de Oliveira, Haddad, Jorge Luiz, Schmidt, André, Marin, José Antônio
Publicado 2016

Aspirin plus verapamil relieves angina and perfusion abnormalities in patients with coronary microvascular dysfunction and Chagas disease: a pilot non-randomized study

por Pavão, Rafael Brolio, Moreira, Henrique Turin, Pintya, Antonio Oswaldo, Haddad, Jorge Luis, Badran, André Vannuchi, Lima-Filho, Moysés de Oliveira, Lago, Igor Matos, Chierice, João Reynaldo Abbud, Schmidt, André, Marin-Neto, J. Antonio
Publicado 2021